(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Clinical trial NCT05767879 · UNKNOWN

Trial details

NCT number: NCT05767879
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage III In-Transit Metastasis of Cutaneous Melanoma

Start date: 2022-01-01
Primary completion: 2026-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.